Anzeige
Mehr »
Donnerstag, 30.10.2025 - Börsentäglich über 12.000 News
Die 80-Milliarden-Dollar-Nuklear-Renaissance: Warum Uran der heißeste Sektor der Welt ist
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiMSD, Eisai abandon combination trial in liver cancer
MiBridgeBio two for two as rare disease drug aces ph3 trial
MiSpecialty meds lift GSK's outlook in Walmsley's swan song
MiFalling flu vaccine sales in US stall CSL's Seqirus spinout
MiLilly partners NVIDIA to build 'most powerful' supercomputer
DiTexas sues J&J, Kenvue over Tylenol autism claim
DiCampaign seeks to plug HIV care gap for UK women
DiMapLight shares track up after $251m IPO
DiGSK strikes again, adding COPD candidate in $745m deal
DiNovartis' new drugs outweigh Entresto decline in Q3
MoCRISPR biotech Intellia plummets as trial paused for safety
MoOrganon CEO resigns over 'improper' contraceptive sales
MoAs Blenrep returns, GSK adds another ADC to cancer pipeline
MoPressure rises on Novo as Innovent drug tops Ozempic
MoNovartis makes $12bn wager on RNA drugs with Avidity buy
FrChugai buys 'Asia lag' firm Renalys for $98m upfront
FrAZ, Organon fall foul of UK's code on pharma promotion
FrBayer's prostate cancer drug Nubeqa cleared for NHS use
FrICER says US new drug launch prices have risen sharply
FrGSK's Blenrep's back in US, but with a narrower label
23.10.George's triple therapy for hypertension hits mark in stroke
23.10.Google claims quantum advance could speed up drug discovery
23.10.Moderna drops mRNA jab for CMV after phase 3 fail
23.10.Alector ditches GSK-partnered dementia drug and cuts staff
22.10.Alkermes bets $2.1bn on Avadel and its narcolepsy drug